Tobacco mosaic virus and the virescence of biotechnology
Open Access
- 29 March 1999
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 354 (1383), 665-673
- https://doi.org/10.1098/rstb.1999.0419
Abstract
There is a growing realization that a modern combination of molecular biology and agriculture will provide a photosynthetic basis for the biosynthesis of an increasing variety of complex and valuable molecules. This ‘greening’ of biotechnology may impact on the global environment in many beneficial ways, but will perhaps have its most significant impact on human health. In the past decade, the capacity to use plants as an expanded source of therapeutics has grown through the accelerated development of effective viral transfection vectors for gene transfer to cultivated crops. Recombinant vectors based on tobacco mosaic virus (TMV) and other members of the Tobamovirus genus are now used to transfect commercially meaningful quantities of plant biomass cultivated in enclosed greenhouses and multiacre fields. Viral RNA promoters are effectively manipulated for the synthesis of recombinant messenger RNAs in whole plants. Chimeric plant virus and virus–like particles are designed for peptide production and display from recombinant structural protein–gene fusions. Gene functions are assessed and modified by either virus–mediated expression or cytosolic inhibition of expression at the RNA level. Recombinant virus populations, propagated by inoculating plants with infectious RNA transcripts or recombinant virions, have proved to be genetically stable over product–manufacturing cycles. Large volumes of highly purified protein products isolated from transfected foliage conform reproducibly to the specifications required for well–characterized biologics. In some cases, they exceed the specific activities of molecules purified from alternative recombinant and native sources. The resulting products are then formulated according to the developing national regulatory guidelines appropriate for agriculture–based manufacturing. Each of these innovations was first realized by researchers using clones of tobamovirus genes and recombinant genomes. This progress is founded on the heritage of a century of fundamental TMV research.Keywords
This publication has 47 references indexed in Scilit:
- Functional integration of non‐native carotenoids into chloroplasts by viral‐derived expression of capsanthin–capsorubin synthase in Nicotiana benthamianaThe Plant Journal, 1998
- Structure-function Relationship Between Tobacco Mosaic Virus Coat Protein and Hypersensitivity in Nicotiana sylvestrisJournal of Molecular Biology, 1994
- The signal for a leaky UAG stop codon in several plant viruses includes the two downstream codonsJournal of Molecular Biology, 1991
- Visualization of protein-nucleic acid interactions in a virusJournal of Molecular Biology, 1989
- Plant viruses: A tool‐box for genetic engineering and crop protectionBioEssays, 1989
- Bacterial Gene Inserted in an Engineered RNA Virus: Efficient Expression in Monocotyledonous Plant CellsScience, 1986
- Development of a Genetically–Engineered, Candidate Polio Vaccine Employing the Self–Assembling Properties of the Tobacco Mosaic Virus Coat ProteinNature Biotechnology, 1985
- Expression of a bacterial gene in plants by using a viral vectorNature, 1984
- Production of Mutants of Tobacco Mosaic Virus by Chemical Alteration of its Ribonucleic Acid in vitroNature, 1958
- Local Lesions in Tobacco MosaicBotanical Gazette, 1929